Patent Application
Provisional
App. No. 63/390,780
· Confirmation No. 7885
FUSION PROTEIN INHIBITORS OF KLK5
Applicant:
BioCryst Pharmaceuticals, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-01-30 | SES.LOSS.PC |
Notification of loss of entitlement to small entity status via PC | 1 | View | |
| 2022-08-02 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-07-20 | SPEC |
Specification | 54 | View | |
| 2022-07-20 | CLM |
Claims | 8 | View | |
| 2022-07-20 | ABST |
Abstract | 1 | View | |
| 2022-07-20 | TR.PROV |
Provisional Cover Sheet (SB16) | 2 | View | |
| 2022-07-20 | ADS |
Application Data Sheet | 5 | View | |
| 2022-07-20 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-07-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Yarlagadda S. Babu
Birmingham, AL
Xilin Chen
Alpharetta, GA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 25181
- Docket No.
- BPX-05060
- Confirmation No.
- 7885
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2022-11-17
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/390,780
- Filed
- 2022-07-20
External Links